Imaging pancreatic beta-cells with PET neuroimaging agent 11C-PHNO
Diseases of the Nervous System
What is the purpose of this trial?
We are conducting a PET imaging study to develop a way to measure the number of insulin secreting cells in the pancreas. This study is intended for people diagnosed with Type 2 Diabetes who are otherwise in good physical health and well controlled on insulin. The study requires 2-3 visits over several weeks.
- Ages18 years - 65 years
- Trial withYale University School of Medicine
- Start Date09/05/2017
- End Date07/31/2021
- Last Updated07/15/2021
- Study HIC#2000021287